Samsung Biologics said Wednesday that it is participating in BioProcess International 2024, a global biopharmaceutical ...

The Biosimilar Red Tape Elimination Act aims to increase the market share of biosimilars. It could drive costs higher.

As CDMOs across the industry continue to face pressure from a fluctuating biopharma business environment, AGC Biologics is ...

Switching between adalimumab and adalimumab-fkjp in Phase 3 study in patients with chronic plaque psoriasis supports ...

Listen to this article Halethorpe-based biologics company Fzata Inc. Tuesday announced it received a five-year, UG3/UH3 ...

Biocon Biologics presents new dermatology data from two clinical studies at EADV Congress 2024: Our Bureau, Bengaluru Wednesday, September 25, 2024, 13:40 Hrs [IST] Biocon Biologi ...

Biocon Biologics presents dermatology data at EADV 2024 Congress, showcasing interchangeability and biosimilarity of ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...

Dr Linda Zuckerman, EVP and global head of biotherapeutics at Just Evotec Biologics added, “With this facility, we extend our ...

ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high ...

Analysts have recently evaluated ADMA Biologics and provided 12-month price targets. The average target is $18.25, ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) ...